These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34372569)

  • 1. Hepatitis C Virus Infection in Persons Who Inject Drugs in the Middle East and North Africa: Intervention Strategies.
    Khalsa JH; Mathur P
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
    World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis.
    Mahmud S; Kouyoumjian SP; Al Kanaani Z; Chemaitelly H; Abu-Raddad LJ
    Ann Epidemiol; 2018 Jul; 28(7):452-461. PubMed ID: 29661680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.
    Ramia S; Melhem NM; Kreidieh K
    Infection; 2012 Feb; 40(1):1-10. PubMed ID: 22237470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.
    Mohamoud YA; Miller FD; Abu-Raddad LJ
    World J Gastroenterol; 2014 Sep; 20(36):12734-52. PubMed ID: 25278675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
    Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
    PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
    Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
    AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key associations for hepatitis C virus genotypes in the Middle East and North Africa.
    Mahmud S; Chemaitelly HS; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ
    J Med Virol; 2020 Mar; 92(3):386-393. PubMed ID: 31663611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.
    Morris MD; Mirzazadeh A; Evans JL; Briceno A; Coffin P; Hahn JA; Page KA
    Drug Alcohol Depend; 2019 May; 198():133-135. PubMed ID: 30921649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
    Iversen J; Wand H; McManus H; Dore GJ; Maher L
    Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.
    Tatara E; Gutfraind A; Collier NT; Echevarria D; Cotler SJ; Major ME; Ozik J; Dahari H; Boodram B
    PLoS One; 2022; 17(3):e0264983. PubMed ID: 35271634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa.
    Chaabna K; Mohamoud YA; Chemaitelly H; Mumtaz GR; Abu-Raddad LJ
    Syst Rev; 2014 Dec; 3():146. PubMed ID: 25516265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns.
    Mahmud S; Al-Kanaani Z; Chemaitelly H; Chaabna K; Kouyoumjian SP; Abu-Raddad LJ
    J Med Virol; 2018 Jan; 90(1):131-141. PubMed ID: 28842995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.
    Heijnen M; Mumtaz GR; Abu-Raddad LJ
    J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on Mahmud et al. (2020): Hepatitis C elimination efforts need to include people who inject drugs in the Middle East and North Africa.
    Walsh N
    Addiction; 2020 Jul; 115(7):1263-1264. PubMed ID: 32293761
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
    Arain A; Robaeys G
    World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.
    Harfouche M; Chemaitelly H; Mahmud S; Chaabna K; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ
    Epidemiol Infect; 2017 Nov; 145(15):3243-3263. PubMed ID: 28988562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.
    Zeremski M; Zibbell JE; Martinez AD; Kritz S; Smith BD; Talal AH
    World J Gastroenterol; 2013 Nov; 19(44):7846-51. PubMed ID: 24307778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.